Matches in SemOpenAlex for { <https://semopenalex.org/work/W2150518447> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W2150518447 abstract "Abstract Background Myofibrillogenesis regulator 1 (MR-1) is overexpressed in human cancer cells and plays an essential role in cancer cell growth. However, the significance of MR-1 in human ovarian cancer has not yet been explored. The aim of this study was to examine whether MR-1 is a predictor of ovarian cancer and its value as a therapeutic target in ovarian cancer patients. Methods Reverse-transcription polymerase chain reaction (PCR) and quantitative real-time PCR were used to detect MR-1 mRNA levels in tissue samples from 26 ovarian cancer patients and 25 controls with benign ovarian disease. Anti-MR-1 polyclonal antibodies were prepared, tested by ELISA and western blotting, and then used for immunohistochemical analysis of the tissue samples. Adhesion and invasion of 292T cells was also examined after transfection of a pMX-MR-1 plasmid. Knockdown of MR-1 expression was achieved after stable transfection of SKOV3 cells with a short hairpin DNA pGPU6/GFP/Neo plasmid against the MR-1 gene. In addition, SKOV3 cells were treated with paclitaxel and carboplatin, and a potential role for MR-1 as a therapeutic target was evaluated. Results MR-1 was overexpressed in ovarian cancer tissues and SKOV3 cells. 293T cells overexpressed MR-1, and cellular spread and invasion were enhanced after transfection of the pMX-MR-1 plasmid, suggesting that MR-1 is critical for ovarian cancer cell growth. Knockdown of MR-1 expression inhibited cell adhesion and invasion, and treatment with anti-cancer drugs decreased its expression in cancer cells. Taken together, these results provide the first evidence of the cellular and molecular mechanisms by which MR-1 might serve as a novel biological marker and potential therapeutic target for ovarian cancer. Conclusions MR-1 may be a biomarker for diagnosis of ovarian cancer. It may also be useful for monitoring of the effects of anti-cancer therapies. Further studies are needed to clarify whether MR-1 is an early diagnostic marker for ovarian cancer and a possible therapeutic target." @default.
- W2150518447 created "2016-06-24" @default.
- W2150518447 creator A5005214697 @default.
- W2150518447 creator A5048843854 @default.
- W2150518447 creator A5058232009 @default.
- W2150518447 creator A5077600873 @default.
- W2150518447 creator A5089504168 @default.
- W2150518447 date "2011-06-25" @default.
- W2150518447 modified "2023-10-17" @default.
- W2150518447 title "Myofibrillogenesis regulator 1 (MR-1) is a novel biomarker and potential therapeutic target for human ovarian cancer" @default.
- W2150518447 cites W1979687059 @default.
- W2150518447 cites W2010111184 @default.
- W2150518447 cites W2070335110 @default.
- W2150518447 cites W2115305202 @default.
- W2150518447 cites W2119796275 @default.
- W2150518447 cites W2120271502 @default.
- W2150518447 cites W2154154147 @default.
- W2150518447 cites W2155252547 @default.
- W2150518447 cites W2159528039 @default.
- W2150518447 cites W2164643159 @default.
- W2150518447 cites W2171283491 @default.
- W2150518447 cites W2228364734 @default.
- W2150518447 cites W2330638116 @default.
- W2150518447 doi "https://doi.org/10.1186/1471-2407-11-270" @default.
- W2150518447 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3132198" @default.
- W2150518447 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21702971" @default.
- W2150518447 hasPublicationYear "2011" @default.
- W2150518447 type Work @default.
- W2150518447 sameAs 2150518447 @default.
- W2150518447 citedByCount "17" @default.
- W2150518447 countsByYear W21505184472012 @default.
- W2150518447 countsByYear W21505184472013 @default.
- W2150518447 countsByYear W21505184472014 @default.
- W2150518447 countsByYear W21505184472015 @default.
- W2150518447 countsByYear W21505184472016 @default.
- W2150518447 countsByYear W21505184472017 @default.
- W2150518447 countsByYear W21505184472018 @default.
- W2150518447 countsByYear W21505184472021 @default.
- W2150518447 countsByYear W21505184472022 @default.
- W2150518447 crossrefType "journal-article" @default.
- W2150518447 hasAuthorship W2150518447A5005214697 @default.
- W2150518447 hasAuthorship W2150518447A5048843854 @default.
- W2150518447 hasAuthorship W2150518447A5058232009 @default.
- W2150518447 hasAuthorship W2150518447A5077600873 @default.
- W2150518447 hasAuthorship W2150518447A5089504168 @default.
- W2150518447 hasBestOaLocation W21505184471 @default.
- W2150518447 hasConcept C121608353 @default.
- W2150518447 hasConcept C126322002 @default.
- W2150518447 hasConcept C153911025 @default.
- W2150518447 hasConcept C173396325 @default.
- W2150518447 hasConcept C2777292972 @default.
- W2150518447 hasConcept C2780427987 @default.
- W2150518447 hasConcept C502942594 @default.
- W2150518447 hasConcept C54009773 @default.
- W2150518447 hasConcept C54355233 @default.
- W2150518447 hasConcept C62112901 @default.
- W2150518447 hasConcept C71924100 @default.
- W2150518447 hasConcept C81885089 @default.
- W2150518447 hasConcept C86803240 @default.
- W2150518447 hasConcept C96232424 @default.
- W2150518447 hasConceptScore W2150518447C121608353 @default.
- W2150518447 hasConceptScore W2150518447C126322002 @default.
- W2150518447 hasConceptScore W2150518447C153911025 @default.
- W2150518447 hasConceptScore W2150518447C173396325 @default.
- W2150518447 hasConceptScore W2150518447C2777292972 @default.
- W2150518447 hasConceptScore W2150518447C2780427987 @default.
- W2150518447 hasConceptScore W2150518447C502942594 @default.
- W2150518447 hasConceptScore W2150518447C54009773 @default.
- W2150518447 hasConceptScore W2150518447C54355233 @default.
- W2150518447 hasConceptScore W2150518447C62112901 @default.
- W2150518447 hasConceptScore W2150518447C71924100 @default.
- W2150518447 hasConceptScore W2150518447C81885089 @default.
- W2150518447 hasConceptScore W2150518447C86803240 @default.
- W2150518447 hasConceptScore W2150518447C96232424 @default.
- W2150518447 hasIssue "1" @default.
- W2150518447 hasLocation W21505184471 @default.
- W2150518447 hasLocation W21505184472 @default.
- W2150518447 hasLocation W21505184473 @default.
- W2150518447 hasLocation W21505184474 @default.
- W2150518447 hasOpenAccess W2150518447 @default.
- W2150518447 hasPrimaryLocation W21505184471 @default.
- W2150518447 hasRelatedWork W2131998981 @default.
- W2150518447 hasRelatedWork W2347764733 @default.
- W2150518447 hasRelatedWork W3043361538 @default.
- W2150518447 hasRelatedWork W3045584038 @default.
- W2150518447 hasRelatedWork W3049178086 @default.
- W2150518447 hasRelatedWork W3113198240 @default.
- W2150518447 hasRelatedWork W3113334872 @default.
- W2150518447 hasRelatedWork W3119000106 @default.
- W2150518447 hasRelatedWork W4307772448 @default.
- W2150518447 hasRelatedWork W4322718626 @default.
- W2150518447 hasVolume "11" @default.
- W2150518447 isParatext "false" @default.
- W2150518447 isRetracted "false" @default.
- W2150518447 magId "2150518447" @default.
- W2150518447 workType "article" @default.